Replies to post #140842 on Anavex Life Sciences Corp (AVXL)

[georgesk]

The quest to promote the idea that A2-73 is not tolerable forcing low dose in the P2a Part B trial and beyond has no basis in fact.

I'm not making that claim, far from it. Not my expertise.

Just curious what the dosage will be for Rett trial. It has to be lower, the target population is children with smaller body mass.